# US 2024/0002920 A1 · METHOD AND KIT FOR DETECTING DNA METHYLATION BASED ON QUANTITATIVE POLYMERASE CHAIN REACTION (qPCR)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002920 A1
- Document ID: US20240002920A1
- Status: Published application
- Kind: A1
- Application number: 18/252,844
- Filed: 2022-11-02
- Published: 2024-01-04
- Earliest claimed: 2021-11-05
- Inventors: Yunfeng ZHU
- Web page: https://patentgrep.com/patent/US20240002920A1

## CPC

- C12Q 1/6851: Quantitative amplification
- C12Q 1/68: involving nucleic acids
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 2600/154: Methylation markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided is a method and kit for detecting DNA methylation based on quantitative polymerase chain reaction (qPCR). The present disclosure achieves the detection of DNA methylation based on qPCR, where PCR is used to prepare fragments of different DNA methylation levels through base incorporation, and then the fragments are subjected to qPCR detection with two programs respectively to get ΔCt and establish a correspondence between ΔCt and a DNA methylation level. The method evaluates a DNA methylation level of a target gene by detecting ΔCt of the target gene. The present disclosure establishes a new convenient method for detecting a DNA methylation difference. According to verification results of experiments with lung cancer and colorectal cancer plasma samples, the method has simple operations, short detection time, and accurate and reliable results, is suitable for the detection of all types of methylated DNA fragments, and has high application values.

## Claims

### Claim at position 1

1-14. canceled

### Claim 15

A kit for detecting DNA methylation based on quantitative polymerase chain reaction (qPCR), comprising parameter settings for PCR with two programs, which denature conditions are conducted in high temperature and low temperature respectively, wherein the ΔCt obtained by subtracting of the Ct value of qPCR conducted in two programs with same reaction mixture, and the following components: a Taq enzyme premix system, primers and probes of target genes for qPCR , and reagents for plotting a reference curve.

### Claim 16 (depends on 15)

The kit according to claim 15, (1) wherein the reagents for plotting the reference curve comprise deoxynucleotide triphosphate (dNTP) reagents with different proportions of methylated cytosine and a common reagent for polymerase chain reaction (PCR);
(2) wherein the target genes for detection of lung cancer or CRC comprises, but is not limited to, one or more selected from the group consisting of the following genes: APC, SHOX2, Apobec3B, P53, AID, HOXD12, Alu, SDC2, WDR17, and ADHFE1.

### Claim 17 (depends on 16)

The kit according to claim 16, wherein the dNTP reagents with different proportions of methylated cytosine each comprise equal molar concentrations of deoxyadenosine triphosphate (dATP), deoxythymidine triphosphate (dTTP), deoxyguanosine triphosphate (dGTP), and a reagent A; and
the reagent A is 5′-methyl-deoxycytidine triphosphate (5′-m-dCTP) and/or deoxycytidine triphosphate (dCTP).

### Claim 18 (depends on 17)

The kit according to claim 17, wherein in the reagent A, a molar ratio of the 5′-m-dCTP to the dCTP falls into the parameters as follows: 1:0, 1:(1-30), or 0:1.

### Claim 19 (depends on 15)

A method for detecting DNA methylation, comprising the following steps:
1. using the primers and probes in the kit according to claim 15 to prepare a reaction system for qPCR detection, and conducting high-temperature denaturation amplification and low-temperature denaturation amplification to obtain CtX-HT for the high-temperature denaturation amplification and CtX-LH for the low-temperature denaturation amplification;
2) substituting CtX-LH in and CtX-HT obtained in step 1) into equation I to obtain ΔCtx of a target gene,
ΔCtx=CtX-LH−CtX-HT equation I
wherein CtX-LH represents a Ct value of an X gene when amplified under low-temperature denaturation, CtX-HT represents a Ct value of an X gene when amplified under high-temperature denaturation, and X represents a target gene;
3) using the reagents for plotting the reference curve in the kit according to claim 15 to amplify fragments of different DNA methylation levels for the target gene, subjecting resulting PCR data to the operations in step 1) and step 2) to obtain ΔCtx′ of the fragments of different DNA methylation levels, and based on a logarithm relationship between different proportions of methylated cytosine and ΔCtx′, plotting the reference curve; and
4) comparing ACtx of the target gene in step 2) with ΔCtx′ in the reference curve in step 3) to obtain a proportion of methylated cytosine in the target gene, such as to determine a DNA methylation level of the target gene.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the target gene comprises, but is not limited to, one or more selected from the group consisting of the following genes: APC, SHOX2, Apobec3B, P53, AID, HOXD12, Alu, SDC2, WDR17, and ADHFE1.

### Claim 21 (depends on 19)

The method according to claim 19, wherein reaction conditions for the high-temperature denaturation amplification are as follows: predenaturation at 95° C. for 5 min; and 94° C. for 5 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 45 cycles; and
reaction conditions for the low-temperature denaturation amplification are as follows: 85° C. to 88° C. for 15 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 18 cycles; and 94° C. for 5 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 27 cycles.

### Claim 22 (depends on 20)

The method according to claim 20, wherein reaction conditions for the high-temperature denaturation amplification are as follows: predenaturation at 95° C. for 5 min; and 94° C. for 5 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 45 cycles; and
reaction conditions for the low-temperature denaturation amplification are as follows: 85° C. to 88° C. for 15 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 18 cycles; and 94° C. for 5 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 27 cycles.

### Claim 23 (depends on 15)

A method for distinguishing a DNA methylation change of one study population from a DNA methylation change of the other study population by using the kit according to claim 15.

### Claim 24 (depends on 23)

The method according to claim 23, wherein the target gene comprises, but is not limited to, one or more selected from the group consisting of the following genes: APC, SHOX2, Apobec3B, P53, AID, HOXD12, Alu, SDC2, WDR17, and ADHFE1.

### Claim 25 (depends on 23)

The method according to claim 23, wherein reaction conditions for the high-temperature denaturation amplification are as follows: predenaturation at 95° C. for 5 min; and 94° C. for 5 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 45 cycles; and
reaction conditions for the low-temperature denaturation amplification are as follows: 85° C. to 88° C. for 15 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 18 cycles; and 94° C. for 5 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 27 cycles.

### Claim 26 (depends on 24)

The method according to claim 24, wherein reaction conditions for the high-temperature denaturation amplification are as follows: predenaturation at 95° C. for 5 min; and 94° C. for 5 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 45 cycles; and
reaction conditions for the low-temperature denaturation amplification are as follows: 85° C. to 88° C. for 15 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 18 cycles; and 94° C. for 5 s, 60° C. to 62° C. for 15 s, and 72° C. for 30 s, with 27 cycles.

### Claim 27 (depends on 23)

The method according to claim 23, wherein when the target gene comprises two or more target genes, a method for distinguishing a DNA methylation change of one study population from a DNA methylation change of the other study population comprises the following steps:
after ΔCt of each target gene is obtained, subjecting ΔCt of a target gene corresponding to each of samples of a population 1 and samples of a population 2 to statistical regression analysis to obtain a threshold and a weight value equation II for joint detection of target genes, wherein ΔCt of each target gene is substituted into the weight value equation II to calculate a weight value for joint detection of multiple target genes of each sample,
weight value for joint detection of multiple target genes=a1×ΔCtx1+a2×ΔCtx2 +. . . +an×ΔCtxn equation II
wherein “a1”, “a2”, and “an” each represent a corresponding coefficient obtained during statistical analysis of each target gene;
qualitative comparison between the two populations: comparing a weight value of each of the samples in the population 1 and the samples in the population 2 with a threshold obtained by binary logistic regression analysis, wherein a sample with a weight value lower the threshold is a lowly methylated sample and is defined as negative, and a sample with a weight value higher than the threshold is a highly methylated sample and is defined as positive; and determining a difference between the two populations through statistical analysis; and
differential determination between the two populations: calculating a mean value of weight values of the samples in the population 1 and a mean value of weight values of the samples in the population 2, and conducting T test analysis, wherein when the mean value of the weight values of the samples in the population 1 is significantly different from the mean value of the weight values of the samples in the population 2, it indicates that there is a significant DNA methylation difference between the two populations.

### Claim 28 (depends on 23)

The method according to claim 23, wherein the two study populations are a healthy population and a lung cancer patient population.

### Claim 29 (depends on 24)

The method according to claim 24, wherein the two study populations are a healthy population and a lung cancer patient population.

### Claim 30 (depends on 23)

The method according to claim 23, wherein the two study populations are a healthy population and a colorectal cancer (CRC) patient population.

### Claim 31 (depends on 24)

The method according to claim 24, wherein the two study populations are a healthy population and a colorectal cancer (CRC) patient population.
